Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
04/2007
04/24/2007US7208300 Enzymatic polypetide for use in the treatment of aneurysms and artheroslerosis
04/24/2007US7208280 Controlling gene expression in tissue
04/24/2007US7208273 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia
04/24/2007US7208270 Detecting demyelinating nervous system disorder by measurement of stem cell factor (SCF)-apoptosis-response gene protein(SARG-1-) protein; antiproliferative agents; microtubule associated protein 1(map1a); cancer screening
04/19/2007WO2007044648A2 Oncohumouse
04/19/2007WO2007044450A2 Compositions and methods for the treatment of cancer
04/19/2007WO2007043589A1 Animal model of schizophrenia
04/19/2007WO2007043404A1 Saspase knockout animal
04/19/2007WO2007043346A1 Method for producing nuclear-transplanted egg
04/19/2007WO2007010398A3 Caveolin-3 and in vitro culture of hepatitis c virus
04/19/2007WO2006116541A3 Tat-002 and methods of assessing and treating cancer
04/19/2007WO2006110309A9 Transgenic mice expressing a unique b cell population and methods of use
04/19/2007WO2006093661A3 A method of truncating both ends of a large piece of dna
04/19/2007WO2002066614A3 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system
04/19/2007US20070089179 provides cell lines and transgenic animals for use in identifying modulators of SREBP2gc transcription factors; provides therapeutic agents that modulate SREBP2gc signaling for use as fertility modulators; drug screening
04/19/2007US20070089178 Modified Organs and Cells for Xenotransplantation
04/19/2007US20070089177 Transgenic animal and methods for decreasing cardiac cell death via cardiac-specific SIR2alpha overexpression
04/19/2007US20070089176 Cytokine involved in epithelial-mesenchymal transition
04/19/2007US20070089175 Mating a transgenic mouse whose genome encodes mouse perlecan, a large multidomain proteoglycan that binds and cross-links extracellular matrix (ECM) components and cell surface molecules, domains, with a second transgenic mouse whose genome encodes the human C terminal of A beta precursor protein
04/19/2007US20070087407 Hepatitis C receptor protein CD81
04/19/2007US20070087378 Polynucleotide and polypeptide fat metabolism regulators and uses thereof
04/19/2007US20070087343 Method of detecting gene expression and kit and apparatus to be used therein
04/19/2007US20070087342 Secreted proteins
04/19/2007US20070087008 Rab9a, rab11a, and modulators thereof related to infectious disease
04/19/2007US20070086946 Assay
04/19/2007CA2658833A1 Compositions and methods for the treatment of cancer
04/19/2007CA2609116A1 Animal model of schizophrenia
04/18/2007EP1774318A2 Models and methods for nociception, pain transduction, and screening for analgesic compounds
04/18/2007EP1774317A1 IMMUNE-COMPROMISED TRANSGENIC MICE EXPRESSING HUMAN HEPATOCYTE GROWTH FACTOR (hHGF)
04/18/2007EP1774040A2 Genetic diagnostic method for scd risk stratification
04/18/2007EP1774036A2 Gene targeting in eukaryotic cells by group ii intron ribonucleoprotein particles
04/18/2007EP1335976B1 Modifier of organelle metalbolism
04/18/2007EP1334194B1 Imaging, diagnosis and treatment of disease
04/18/2007EP1324652B1 Transgenic drosophila melanogaster expressing beta amyloid
04/18/2007CN1950502A Regulation of cardiac contractility and heart failure propensity
04/18/2007CN1947501A Method for artificial propagation of Elopichthys bambus
04/18/2007CN1947500A Method for raising chickens
04/18/2007CN1311083C Biological control by conditional dominant lethal genetic system
04/18/2007CN1311081C Stem cell differentiation
04/17/2007US7205148 Using homologous recobination to disrupt introns into exons and generate gene expression mutants; site directed mmutagenesis
04/17/2007CA2127450C Transgenic animal models for alzheimer's disease
04/17/2007CA2100690C Megakaryocyte differentiation factor
04/12/2007WO2007041694A2 Compositions and methods for treating inflammation
04/12/2007WO2007041438A2 Compositions comprising glycerophosphodiester phosphodiesterase (gde) and uses thereof
04/12/2007WO2007039920A1 A method for the transfer of episomal vectors into animal cells
04/12/2007WO2006130855A3 Method of targeted gene delivery using viral vectors
04/12/2007US20070083941 Rat TRPM7 polynucleotide and encoded protein
04/12/2007US20070083940 Transformed silkworm producing human collagen
04/12/2007CA2665080A1 Regulatable fusion promoters
04/12/2007CA2624730A1 Compositions and methods for treating inflammation
04/11/2007EP1679959B1 A method for inducing the sexual maturation of lugworms
04/11/2007EP1644733B1 Screening methods employing zebrafish and the blood brain barrier
04/11/2007CN1947006A Immunocompromised rodents as dual color tumor models
04/11/2007CN1943332A Method for producing super fine silk yarn
04/11/2007CN1943331A Detachable movable silkworm frame
04/11/2007CN1943330A Use of earthworm in check experiment
04/11/2007CN1943325A Ground raising equipment for egg ducle in pens and its raising method
04/11/2007CN1309737C Recombinant gelatins
04/11/2007CN1309734C Polypeptides involved in immune response
04/10/2007US7202395 Assessment method
04/10/2007US7202394 Animal with the mass expression of human gene and test method by using the animal
04/10/2007US7202393 Mouse with a gene responsible for having a higher blood sugar level as compared to a normal strain mouse, being positive in test for urine sugar, exhibiting no inflammation of the pancreatic islets and having a blood insulin concentration higher than a normal strain mouse
04/10/2007US7202392 Using transgenic rodents to evaluate effects of a plurality of different treatments or cosmetic compounds on tissues; drug screening; animal testing
04/10/2007US7202085 Acylated Homoserine Lactone (AHL) compounds and AHL receptors derived from bacterial quorum sensing systems; inducible or repressible promotors regulate gene expression in plants and plant cells
04/10/2007US7202025 Control of gene expression
04/10/2007CA2400361C Immortalized vascular pericyte line
04/10/2007CA2316808C Transgenic rabbit that expresses a functional human lipoprotein (a)
04/10/2007CA2311599C Transgenic non-human mammals with an oncogenic mutant of raf gene 1
04/10/2007CA2254931C Human monoclonal antibodies to the hepatitis b surface antigen
04/10/2007CA2242382C Compositions and methods for mediating cell cycle progression
04/05/2007WO2007036041A1 Sialidase inhibitors for the treatment of cardiovascular disease
04/05/2007WO2007036028A1 Compositions for and methods of granzyme b inhibition
04/05/2007WO2006073601A3 Methods and compositions for rna interference
04/05/2007US20070079392 Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders
04/05/2007US20070079391 Hyperlipemia/hyperalbuminemia model animal
04/05/2007US20070079390 Animal model for schizophrenia
04/05/2007US20070079389 Method for screening PTPzeta activity promoter or inhibitor
04/05/2007US20070079388 Human hookworm model and method for maintaining human hookworm in a non-human primate
04/05/2007US20070074666 Method for including the sexual maturation of lugworms
04/05/2007CA2623957A1 Compositions for and methods of granzyme b inhibition
04/04/2007EP1770164A2 Streptococcus pneumoniae antigens and vaccines
04/04/2007EP1769677A2 Method of identifying therapeutic compounds which can be used for the treatment and/or prevention of infections and diseases caused by human herpesviruses
04/04/2007EP1769085A2 Detection of cellular stress
04/04/2007EP1768486A2 Chimeric avian-based screening system containing mammalian grafts
04/04/2007EP1414858B1 Single chain camelid vhh antibodies, method for their production in a mammal, and their uses
04/04/2007CN2884892Y Highly-efficient environmental-friendly silkworm rearing rack
04/04/2007CN1942588A Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
04/03/2007US7199281 Insertion nucleoprotein into cells; genetic engineering
04/03/2007US7199280 Generating genetically engineered cells; obtain cells, incubate with nucleotide sequences, transform cells, detect and recover cell containing exogenous nucleotide sequences
04/03/2007US7199279 Expression vector comprising hydrolase regulatory sequences, matrix attachment region (MAR) and transcriptional enhancer for use as gene transfer tools
04/03/2007US7199234 Nucleotide sequences coding telomerase reverse transcriptase (TRT) for diagnosing and treating cancers; antiproliferative agents
04/03/2007US7198950 Self-inactivating plasmid/vector; gene therapy; treating hematological disorders; anticarcinogenic agents
04/03/2007US7198922 Synthesizing polyketide fusion protein comprising acyltransferase domain for use as anthelminthic, insecticide, antitumor, immunosuppressant, fungicidal and/or bactericidal agents
04/03/2007US7198774 Non-invasive localization of a light-emitting conjugate in a mammal
04/03/2007CA2328447C Adeno-associated virus vectors and uses thereof
04/03/2007CA2276459C Novel method for testing the differentiation status in pancreatic cells of a mammal
04/03/2007CA2162397C Ligands for flt3 receptors
04/03/2007CA2089661C Transgenic non-human animals capable of producing heterologous antibodies
03/2007
03/29/2007WO2007034753A1 Remedy for angiogenesis-related disease comprising chondromodulin-i as the active ingredient
03/29/2007WO2007034649A1 Transgenic pig with diabetes and method for producing the same